Relationship between chronic obstructive pulmonary disease and in-hospital management and outcomes in patients with acute myocardial infarction

Kardiologia Polska

Volumn 68, Issue 3, 2010, Pages 294-301

  Dziewierz, Artur ^a   Siudak, Zbigniew ^a   Rakowski, Tomasz ^a   Brzeziński, Michał ^a   Zdzienicka, Joanna ^a   Mielecki, Waldemar ^a   Dubiel, Jacek S ^a   Dudek, Dariusz ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Acute myocardial infarction; Chronic obstructive pulmonary disease; Management; Mortality

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NITRATE; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; AGED; ANGINA PECTORIS; ARTICLE; BLOOD CLOT LYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HOSPITAL SERVICE; HOSPITALIZATION; HUMAN; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT TRANSPORT; PREDICTOR VARIABLE; STROKE; TREATMENT OUTCOME;

EID: 77953757617     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-80.
2. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 2007; 99: 636-41.
3. Berger JS, Sanborn TA, Sherman W, et al. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol 2004; 94: 649-51.
4. Selvaraj CL, Gurm HS, Gupta R, et al. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardiol 2005; 96: 756-9.
5. Gardner SC, Grunwald GK, Rumsfeld JS, et al. Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg 2001; 72: 2033-7.
6. Gao D, Grunwald GK, Rumsfeld JS, et al. Time-varying risk factors for long-term mortality after coronary artery bypass graft surgery. Ann Thorac Surg 2006; 81: 793-9. (Pubitemid 43247641)
7. Dziewierz A, Siudak Z, Rakowski T, et al. More aggressive pharmacological treatment may improve clinical outcome in patients with non-ST-elevation acute coronary syndromes treated conservatively. Coron Artery Dis 2007; 18: 299-303. (Pubitemid 46743714)
8. Dudek D, Siudak Z, Dziewierz A, et al. Local hospital networks for STEMI treatment for a population of half a million inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Malopolska Registry of Acute Coronary Syndromes 2005-2006. Kardiol Pol 2008; 66: 489-97.
9. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416. (Pubitemid 40283098)
10. Truelsen T, Prescott E, Lange P, et al. Lung function and risk of fatal and non-fatal stroke. The Copenhagen City Heart Study. Int J Epidemiol 2001; 30: 145-51. (Pubitemid 32203804)
11. Tamagawa E, van Eeden SF. Impaired lung function and risk for stroke: role of the systemic inflammation response? Chest 2006; 130: 1631-3.
12. Brekke PH, Omland T, Smith P, et al. Underdiagnosis of myocardial infarction in COPD - Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation. Respir Med 2008; 102: 1243-7.
13. Yan AT, Yan RT, Tan M, et al. Treatment and one-year outcome of patients with renal dysfunction across the broad spectrum of acute coronary syndromes. Can J Cardiol 2006; 22: 115-20.
14. Dudek D, Chyrchel B, Siudak Z, et al. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score. Kardiol Pol 2008; 66: 28-34.
15. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA 2007; 298: 765-75.
16. Cooper HA, Domanski MJ, Rosenberg Y, et al. Acute ST-segment elevation myocardial infarction and prior stroke: an analysis from the Magnesium in Coronaries (MAGIC) trial. Am Heart J 2004; 148: 1012-9.
17. Egred M, Shaw S, Mohammad B, et al. Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease. QJM 2005; 98: 493-7.
18. Au DH. Use of beta blockers in patients with COPD. Thorax 2008; 63: 296-8.
19. Ohman EM, Roe MT, Smith SC Jr., et al. Care of non-ST-segment elevation patients: insights from the CRUSADE national quality improvement initiative. Am Heart J 2004; 148: S34-9.
20. Roe MT, Peterson ED, Newby LK, et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J 2006; 151: 1205-13.
21. Gan WQ, Man SF, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-80.
22. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000; 343: 1139-47.
23. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
24. King KM, Humen DP, Teo KK. Cardiac rehabilitation: the forgotten intervention. Can J Cardiol 1999; 15: 979-85.